attachment

Write answers in details

Great, I can do that.
I can provide detailed, exam-style answers for every question visible in your Pharmacology paper image.
Please confirm one thing so I format it exactly as you want:
  1. Full solution for all questions (Q1, Q2, Q3), or
  2. Only selected questions (tell me question numbers), or
  3. Model answer key with headings + bullet points suitable for writing in exam booklet.
Once you confirm, I will write complete, high-yield detailed answers.

Full solutions from standartd pharmacology book

Excellent. Below are full, detailed model answers in standard MBBS pharmacology style (mechanism, rationale, regimen, adverse effects, and key clinical points), written so you can reproduce in exams.

Q-1 (A) Structured long questions


1) Severe postoperative pain treated with morphine

Explain mechanism of action and pharmacological actions of morphine poisoning.
(In many university papers, the wording means: explain MOA + clinical/pharmacological manifestations of morphine toxicity/poisoning.)

A. Mechanism of action of morphine

Morphine is a strong opioid agonist, predominantly at mu (μ) receptors (also weak activity at κ and δ).

Receptor and signaling

  • Opioid receptors are Gi/Go-coupled GPCRs.
  • On activation:
    • ↓ Adenylyl cyclase activity → ↓ cAMP
    • Closes presynaptic voltage-gated Ca²⁺ channels → less release of substance P, glutamate, CGRP
    • Opens postsynaptic K⁺ channels → hyperpolarization and reduced neuronal firing

Net effect

  • Inhibition of nociceptive neurotransmission in:
    • dorsal horn of spinal cord
    • ascending pain pathways
    • supraspinal pain-modulating circuits
  • Also changes emotional perception of pain (limbic system effect).

B. Pharmacological actions (normal therapeutic profile)

  1. CNS
    • Powerful analgesia (somatic and visceral)
    • Sedation, mental clouding
    • Euphoria (sometimes dysphoria)
    • Antitussive action at medullary cough center
    • Miosis (pinpoint pupil) via Edinger-Westphal nucleus
    • Respiratory depression (↓ sensitivity to CO₂)
  2. GIT
    • ↓ Propulsive motility, ↑ segmenting contractions
    • Delayed gastric emptying
    • Constipation
  3. Biliary and smooth muscle
    • Spasm of sphincter of Oddi (biliary colic may worsen)
    • Urinary retention (↑ sphincter tone)
  4. CVS
    • Usually mild effects at therapeutic dose
    • Peripheral vasodilation (histamine release), possible postural hypotension
  5. Endocrine/other
    • Nausea, vomiting (CTZ stimulation)
    • Pruritus/flushing due to histamine

C. Morphine poisoning (opioid overdose): clinical features

Classic triad

  1. Coma / profound CNS depression
  2. Pinpoint pupils (miosis)
    • may become mid-dilated in terminal hypoxia
  3. Respiratory depression (most dangerous; can cause death)

Other signs

  • Slow, shallow breathing, cyanosis
  • Bradycardia, hypotension
  • Hypothermia
  • Reduced bowel sounds, urinary retention
  • Pulmonary edema in severe poisoning

D. Management of morphine poisoning

  1. Airway, breathing, circulation first
    • Maintain airway, oxygen, assisted ventilation if needed
  2. Specific antidote: Naloxone
    • Competitive opioid antagonist (high affinity for μ receptors)
    • IV bolus, repeated or infusion (because naloxone duration < some opioids)
  3. Supportive care
    • Fluids/vasopressor if hypotension
    • Monitor ABG, ECG, SpO₂
    • Observe for renarcotization
  4. In dependence, naloxone may precipitate withdrawal; still life-saving in overdose.

2) Newly diagnosed pulmonary tuberculosis

Describe treatment regimen. Key points while treating TB. What is MDR-TB?

A. Standard treatment regimen for drug-susceptible new pulmonary TB

Current standard (programmatic/WHO-aligned principle): 6-month regimen
  • Intensive phase (2 months):
    H + R + Z + E
    (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol)
  • Continuation phase (4 months):
    H + R
Mnemonic: 2HRZE / 4HR
Usually given as daily fixed-dose combinations, weight-based dosing.

B. First-line anti-TB drugs and key role

  • Isoniazid (H): potent early bactericidal drug
  • Rifampicin (R): sterilizing drug; prevents relapse
  • Pyrazinamide (Z): active in acidic intracellular sites; shortens therapy
  • Ethambutol (E): protects against resistance when susceptibility unknown

C. Key points to consider in TB treatment

  1. Never use monotherapy for active TB.
  2. Adherence is critical
    • DOT/adherence support, counseling
  3. Use correct weight-based doses
  4. Baseline evaluation
    • LFT, renal function if indicated
    • HIV status, diabetes screening
    • Pregnancy status, vision exam when prolonged ethambutol risk
  5. Monitor adverse effects
    • H: hepatitis, peripheral neuropathy (give pyridoxine in risk groups)
    • R: hepatitis, orange discoloration, drug interactions (enzyme inducer)
    • Z: hepatotoxicity, hyperuricemia
    • E: optic neuritis (red-green color vision)
  6. Check sputum/microbiological response per protocol
  7. Contact tracing and infection control
  8. Comorbidities
    • HIV co-treatment and ART timing
    • diabetes control, nutrition
  9. Avoid treatment interruption, because it promotes failure/relapse/resistance.
  10. Drug susceptibility testing (DST) should guide modifications if non-response/resistance.

D. What is MDR-TB?

MDR-TB (Multidrug-resistant TB) = TB caused by Mycobacterium tuberculosis resistant to at least:
  • Isoniazid (H) and
  • Rifampicin (R)
(with or without resistance to other drugs).
Clinical significance:
  • Requires longer, more toxic, costlier second-line regimens.
  • Managed with DST-guided all-oral regimens (commonly including agents like bedaquiline, linezolid, fluoroquinolones etc., as per national/WHO protocol).

Q-2 (B) Attempt any TWO (detailed answers for all three)


1) Case suggestive of enteric fever; widal positive for Salmonella typhi

a) Drugs with duration
b) Mechanism of action and adverse effects (any one drug)

A. Drugs used for typhoid fever (uncomplicated, susceptibility-guided)

Common options (regional resistance pattern matters):
  • Ceftriaxone (parenteral, severe/hospitalized cases)
  • Cefixime (oral in selected uncomplicated cases)
  • Azithromycin (oral; useful where quinolone resistance high)
  • Fluoroquinolones (ciprofloxacin/ofloxacin) only if proven susceptible

Typical durations (exam-friendly)

  • Azithromycin: 5–7 days
  • Cefixime: 10–14 days
  • Ceftriaxone: 10–14 days (or per clinical response)
  • Ciprofloxacin: 7–10 days if organism susceptible
(Always tailor to culture/sensitivity and local guidelines.)

B. One drug in detail (example: Ceftriaxone)

Mechanism of action

  • Third-generation cephalosporin (β-lactam)
  • Binds penicillin-binding proteins (PBPs)
  • Inhibits transpeptidation of peptidoglycan → defective bacterial cell wall synthesis
  • Bactericidal

Adverse effects

  • Hypersensitivity rash, anaphylaxis (rare)
  • Diarrhea, nausea
  • Biliary sludge/pseudolithiasis (especially children, high dose)
  • Injection site pain
  • Rare: C. difficile colitis, hematologic changes
(If exam asks any one drug, azithromycin or ciprofloxacin can also be written similarly.)

2) 8-year-old with ODD + momentary loss of consciousness, staring, eyelid flutter

(typical absence seizures)
a) Drug of choice and suitable alternatives with mechanism
b) Lifelong treatment needed?

A. Diagnosis pattern

  • Brief staring spells, eyelid blinking, sudden onset/offset, minimal postictal confusion
  • Typical of absence seizures (petit mal)

B. Drug of choice (DOC)

Ethosuximide

Mechanism

  • Selective blockade of T-type Ca²⁺ channels in thalamic neurons
  • Suppresses thalamocortical 3-Hz spike-wave discharges
  • Highly effective for pure absence seizures

Adverse effects

  • GI upset, anorexia
  • Drowsiness, fatigue, headache
  • Behavioral changes
  • Rare blood dyscrasias, rash

C. Suitable alternatives

  1. Valproate (sodium valproate)
    • Preferred if mixed seizure types (absence + generalized tonic-clonic)
    • MOA: ↑ GABA (inhibits GABA metabolism), blocks Na⁺ channels, reduces T-type Ca²⁺ currents
  2. Lamotrigine
    • Less effective than ethosuximide/valproate for pure absence but useful alternative
    • MOA: blocks voltage-gated Na⁺ channels, reduces glutamate release

D. Is lifelong treatment needed?

Usually no.
  • Childhood absence epilepsy often has good prognosis.
  • Continue treatment for seizure control; reassess after prolonged seizure-free period (commonly about 2 years seizure-free, plus EEG/clinical judgment).
  • Gradual taper may be attempted under specialist supervision.
  • A subset may persist/convert; hence individualized follow-up is required.

3) 27-year-old female with uncomplicated UTI; pregnant

a) Suitable drug with mechanism
b) Two antimicrobials contraindicated/avoided in pregnancy for UTI with justification

A. Suitable drug in pregnancy (example)

Nitrofurantoin (for uncomplicated cystitis; avoid near term)

Mechanism

  • Reduced by bacterial flavoproteins to reactive intermediates
  • Damages bacterial DNA/ribosomal proteins and metabolic enzymes
  • Concentrates in urine; effective in lower UTI

Notes

  • Good for lower UTI, not pyelonephritis
  • Avoid at term (risk hemolysis in G6PD-deficient newborn)
(Alternative pregnancy-safe options often include amoxicillin-clavulanate, cephalexin, fosfomycin depending on sensitivity.)

B. Two drugs avoided/contraindicated (with reasons)

  1. Fluoroquinolones (e.g., ciprofloxacin)
    • Avoid in pregnancy due to concern for fetal cartilage/joint toxicity (animal data) and safer alternatives available.
  2. Tetracyclines (e.g., doxycycline)
    • Contraindicated: deposition in fetal bone/teeth, tooth discoloration, inhibition of bone growth, maternal hepatotoxicity risk.
(Also often avoided in late pregnancy: TMP-SMX near term due to kernicterus risk and folate effects in early pregnancy.)

Q-3 Write short notes on ANY THREE (all four given)


1) Therapeutic uses and adverse effects of Metronidazole

Therapeutic uses

  • Protozoal infections:
    • Amoebiasis (intestinal and hepatic)
    • Giardiasis
    • Trichomoniasis (treat sexual partners too)
  • Anaerobic bacterial infections:
    • Intra-abdominal, pelvic, dental anaerobic infections
    • Brain abscess (anaerobic component)
  • C. difficile infection (historically; now alternatives often preferred in many guidelines)
  • Part of H. pylori eradication regimens
  • Bacterial vaginosis
  • Surgical prophylaxis for anaerobic contamination (e.g., colorectal)

Mechanism (brief)

  • Nitro group reduced in anaerobes/protozoa to cytotoxic radicals
  • Causes DNA strand breaks and inhibits nucleic acid synthesis
  • Bactericidal/protozoacidal

Adverse effects

  • Metallic taste, nausea, abdominal discomfort
  • Headache, dizziness
  • Dark urine
  • Peripheral neuropathy (prolonged use)
  • Disulfiram-like reaction with alcohol (avoid alcohol during and at least 48–72 h after course)
  • Rare CNS toxicity, leukopenia

2) Compare benzodiazepines vs non-benzodiazepine hypnotics

FeatureBenzodiazepines (e.g., diazepam, lorazepam, nitrazepam)Non-benzodiazepine Z-drugs (zolpidem, zopiclone, zaleplon)
Receptor actionGABA-A positive allosteric modulators at BZD site; broader subunit actionAlso act at BZD site but relatively selective for α1-containing GABA-A (hypnotic)
Main effectsAnxiolytic, sedative-hypnotic, muscle relaxant, anticonvulsantPredominantly hypnotic (sleep induction)
Sleep architectureCan reduce slow-wave sleep; REM effects variableLess disruption of sleep architecture (generally)
Daytime sedationMore likely (especially long-acting drugs)Usually less next-day sedation (agent/dose dependent)
Dependence/tolerancePresent; withdrawal possibleAlso present, but generally somewhat lower risk at short-term use
Anterograde amnesiaCan occurCan occur (e.g., complex sleep behaviors with zolpidem)
UseAnxiety, status epilepticus, muscle spasm, insomniaMainly short-term insomnia
OverdoseSafer than barbiturates; severe CNS depression with alcohol/opioidsSimilar caution; additive CNS depression with alcohol/sedatives
Exam conclusion: Z-drugs are preferred for short-term insomnia when daytime anxiolysis/muscle relaxation is not needed.

3) “Justice” as a bioethical principle in healthcare

Justice means fairness in distribution of healthcare resources, risks, costs, and benefits.

Components

  1. Distributive justice
    • Fair allocation of ICU beds, dialysis slots, organs, vaccines, medicines.
  2. Procedural justice
    • Transparent, consistent, impartial decision-making.
  3. Social justice
    • Attention to vulnerable groups; reducing inequities by class, gender, caste, geography, disability.

In clinical practice

  • Similar patients should be treated similarly.
  • No discrimination on non-medical grounds.
  • Triage should be need- and benefit-based.
  • Rational prescribing: avoid unnecessary expensive therapy when equivalent cheaper options exist.
  • Public health ethics: balancing individual autonomy and population welfare.

Relevance to pharmacology

  • Essential medicines list and generic prescribing
  • Cost-effectiveness and rational use
  • Equitable access to life-saving drugs

4) Selective serotonin reuptake inhibitors (SSRIs)

Drugs

  • Fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine

Mechanism

  • Selective inhibition of serotonin transporter (SERT) at presynaptic terminal
  • ↑ 5-HT in synaptic cleft
  • Minimal direct effect on NE/DA reuptake compared to TCAs

Indications

  • Major depressive disorder
  • Anxiety disorders (GAD, panic disorder, social anxiety)
  • OCD
  • PTSD
  • PMDD
  • Bulimia nervosa (fluoxetine)

Adverse effects

  • GI upset, nausea, diarrhea
  • Insomnia or somnolence
  • Sexual dysfunction (decreased libido, delayed ejaculation, anorgasmia)
  • Initial anxiety/agitation in some patients
  • Weight changes (variable)
  • Hyponatremia/SIADH (elderly)
  • Increased bleeding tendency (platelet serotonin depletion), especially with NSAIDs/anticoagulants
  • Serotonin syndrome (with MAOIs, linezolid, tramadol, triptans etc.)
  • Discontinuation syndrome (notably paroxetine)
  • QT prolongation risk with high-dose citalopram

Important precautions

  • Avoid with MAO inhibitors (washout required)
  • Monitor suicidal risk in adolescents/young adults early in treatment
  • Pregnancy: individualized risk-benefit assessment

Advantages over TCAs

  • Better safety in overdose
  • Fewer anticholinergic and cardiotoxic effects
  • Better tolerability overall

If you want, I can now convert this into a clean exam-writing format (with exact heading style, underlining points, and mnemonic lines) so you can directly memorize and reproduce in university answers.
This is a shared conversation. Sign in to Orris to start your own chat.